Appropriate use of psychotropic drugs in nursing homes

American Family Physician

Volumn 61, Issue 5, 2000, Pages 1437-1446

  Gurvich, Tatyana ^a   Cunningham, Janet A ^a  

^a Glendale Adventist Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT;

ANXIETY; ARTICLE; COGNITIVE DEFECT; DRUG USE; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INSOMNIA; NURSING HOME; SEDATION; TARDIVE DYSKINESIA;

AGED; ALGORITHMS; DRUG UTILIZATION; HEALTH CARE COSTS; HOMES FOR THE AGED; HUMANS; LEGISLATION, MEDICAL; NURSING HOMES; PRACTICE GUIDELINES; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 0034163748     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Christensen DB, Benfield WR. Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients. J Am Geriatr Soc 1998;46:620-5.
2. Siegler EL, Capezuti E, Maislin G, Baumgarten M, Evans L, Strumpf N. Effects of a restraint reduction intervention and OBRA '87 regulations on psychoactive drug use in nursing homes. J Am Geriatr Soc 1997;45:791-6.
3. Omnibus Budget Reconciliation Act of 1987: subtitle C, nursing home reform: PL100-203. Washington, D.C.: National Coalition for Nursing Home Reform, 1987.
4. Health Care Financing Administration. Survey procedures and interpretive guidelines for skilled nursing facilities and intermediate care facilities. Baltimore: U.S. Dept. of Health and Human Services, 1990.
5. Harrington C, Tompkins C, Curtis M, Grant L. Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist 1992;32:822-33.
6. Nursing home survey procedures and interpretive guidelines. 2d ed. Alexandria, Va.: American Society of Consultant Pharmacists, 1999.
7. Slater EJ, Glazer W. Use of OBRA-87 guidelines for prescribing neuroleptics in a VA nursing home. Psychiatr Serv 1995;46:119-21.
8. Borson S, Doane K. The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatr Serv 1997;48:1289-96.
9. Beers M. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531-6.
10. Lantz MS, Giambanco V, Buchalter EN. A ten-year review of the effect of OBRA-87 on psychotropic prescribing practices in an academic nursing home. Psychiatr Serv 1996;47:951-5.
11. Llorente MD, Olsen EJ, Leyva O, Silverman MA, Lewis JE, Rivero J. Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations. J Am Geriatr Soc 1998;46:198-201.
12. Hay DP, Rodriguez MM, Franson KL. Treatment of depression in late life. Clin Geriatr Med 1998;14: 33-46.
13. Drug facts and comparisons. St. Louis: Facts and Comparisons, 1999;264j.
14. Citalopram for depression. Med Lett Drugs Ther 1998;40:113-4.
15. Mirtazapine - a new antidepressant. Med Lett Drugs Ther 1996;38:113-4.
16. Burke WJ, Folks DG, McNeilly DP. Effective use of anxiolytics in older adults. Clin Geriatr Med 1998;14:47-65.
17. Folks DG, Burke WJ. Psychotherapeutic agents in older adults. Sedative hypnotics and sleep. Clin Geriatr Med 1998;14:67-86.
18. Finkel SI. Psychotherapeutic agents in older adults. Antipsychotics: old and new. Clin Geriatr Med 1998;14:87-100.
19. Quetiapine for schizophrenia. Med Lett Drugs Ther 1997;39117-8 [Published erratum in Med Lett Drugs Ther 1998;40:20].
20. Berman I, Merson A, Rachov-Pavlov J. Risperidone in elderly psychiatric patients: an open-labeled trial. Am J Geriatr Psychiatry 1996;4:173-9.
21. Kumar V, Durai UN, Jobe T. Pharmacologic management of Alzheimer's disease. Clin Geriatr Med 1998;14:129-46.
22. Kumar V. Use of atypical antipsychotic agents in geriatric patients: a review. Int J Geriatr Psychopharmacol 1997;1:15-23.